PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,272,517 | lipid uniqu alter rate insulin aggreg lower toxic amyloid aggreg amyloid format hallmark mani medic diseas includ diabet type alzheim parkinson diseas patholog condit misfold protein self assembl form oligom fibril structur heterogen aggreg exhibit larg varieti shape form grow bodi evid point drastic chang lipid profil... | D007328;D010300 | T125;T121;T047;T116 |
36,272,494 | qing xin jie yu granul inhibit ferroptosi stabil atherosclerot plaqu regul gpxxct signal pathway qing xin jie yu granul qxjyg integr tradit chines medicin formula use treat atherosclerot cardiovascular diseas random control trial found qxjyg reduc cardiovascular event experi also verifi qxjyg attenu remodel intestin fl... | D000079403;D058226 | T046;T020;T031;T043 |
36,272,493 | identif high throughput quantif baicalein metabolit plasma urin scutellaria baicalensi georgi contain varieti function compound use tradit drug centuri baicalein highest amount flavonoid found scutellaria baicalensi georgi exert various pharmacolog activ might promis drug treat covid | D000086382;D044950 | T121;T047;T067;T109 |
36,272,492 | morus alba l root decreas melanin synthesi via sphingosin phosphat signal bf cell morus alba l long use beauti mani asian countri region includ anti age hyperpigment | D031625;D008545;D008546 | T191;T050;T002 |
36,272,491 | integr network pharmacolog pharmacolog evalu explor protect mechan ershiwuwei zhenzhu pill ischem stroke ershiwuwei zhenzhu pill ezp repres classic formula tibetan medicin common use treatment various cerebrovascular diseas includ ischem stroke nevertheless efficaci potenti mechan treat yet investig | D004365;D000083242 | T123;T047;T121 |
36,272,490 | xinfeng capsul inhibit inflamm oxid stress rheumatoid arthriti regul linc activ nrfho pathway xinfeng capsul tradit chines medicin compound clinic use year treatment rheumatoid arthriti ra ankylos spondyl osteoarthr extracurricular lesion howev molecular role xfc treatment ra remain unclear | D001169;D001172;D000070918 | T047;T050;T025 |
36,272,410 | hotspot mutat structur enl yeat domain link aberr transcript condens cancer grow evid suggest preval transcript condens chromatin yet mechan format function signific remain larg unclear human cancer seri mutat histon acetyl reader enl creat gain function mutant increas transcript activ abil show mutat cluster enl struc... | D000088202;D009369 | T026;T191 |
36,272,409 | dna topolog regul pam cas interact dna unwind enabl near pamless cleavag thermophil cas crispr cas mediat genom edit depend pam recognit initi dna unwind pam mutat abolish cas bind prohibit edit identifi cas thermophil alicyclobacillus tengchongensi pam interact robust regul dna topolog atca relax pam n cnnn n rnna r a... | D064113;D004926 | T040;T007 |
36,272,408 | rig receptor adopt two differ conform distinguish host viral rna ligand rig essenti innat immun receptor detect respond infect rna virus rig specif recogn uniqu molecular featur viral rna molecul select distinguish close relat rnas abund host cell physic basi exquisit select reveal seri high resolut cryo em structur ri... | D012367;D053487 | T126;T116;T114 |
36,272,401 | bone marrow periost skelet stemprogenitor cell make distinct contribut bone mainten repair fundament question bone biolog concern contribut skelet stemprogenitor cell sscs bone marrow versus periosteum bone repair found sscs adult bone marrow identifi base lepr cre adiponectin crecreer express sscs adult periosteum ide... | D001853;D052242 | T123;T023;T116;T024 |
36,272,399 | associ dexmedetomidin administr outcom critic ill patient sepsi associ acut kidney injuri investig associ dexmedetomidin administr outcom critic ill patient sepsi associ acut kidney injuri sa aki | D020927;D058186;D018805 | T121;T109;T037;T047;T046 |
36,272,394 | marker infect inflamm associ post thrombectomi mortal acut stroke explor relationship marker infect inflamm mortal patient acut ischem stroke underw thrombectomi | D000083242;D000086382;D020521;D002545 | T047;T046;T067 |
36,272,357 | analysi bind warfarin glyoxal methylglyox modifi human serum albumin ultrafast affin extract ultrafast affin extract uae affin microcolumn contain immobil human serum albumin hsa employ evalu effect advanc stage glycat hsa bind warfarin common site specif probe sudlow site protein modif hsa glyoxal go methylglyox mgo c... | D014859;D000075462 | T121;T116;T131;T109 |
36,272,356 | evolut current state instrument analyt supercrit fluid chromatographi supercrit fluid chromatographi contribut signific chiral method develop semi prepar purif drug discoveri sensit issu analyt scale sfc valid use multi vendor inter lab studi quantit achir trace pharmaceut impur use sub particl gradient elut uv detect ... | D025924 | T059 |
36,272,326 | differenti effect ankl constraint foot placement control normal split belt treadmil mediolater ankl moment control contribut gait stabil ankl moment constrain walk shoe ridg underneath sole narrow mediolater support surfac previous studi ankl moment constraint result increas step width decreas degre foot placement cont... | D000842;D000222 | T040;T029 |
36,272,315 | evalu autom presidio anonymis model unstructur radiat oncolog electron medic record australian set electron medic record emr contain valuabl inform clinic research howev presenc person identifi inform pii restrict use anonymis pii emr enabl clinic inform share research purpos sinc limit research relat anonymis australi... | D057286;D018787 | T170;T091;T073 |
36,272,309 | prematur discontinu among individu epilepsi particip epilepsi self manag research intervent manag epilepsi well mew network conduct epilepsi self manag esm intervent develop test archiv clinic trial data analys mew network integr databas mew db howev trial particip fulli benefit esm due prematur discontinu program part... | D000073278;D004827;D047928 | T033;T058;T046;T047 |
36,272,308 | extens pharmacokinet variabl levetiracetam doctor awar levetiracetam present drug linear pharmacokinet current evid extens pharmacokinet variabl real clinic practic | D010889;D004827 | T033;T121;T047;T109 |
36,272,276 | applic surfac plasmon reson imag biosensor determin fibronectin laminin type iv collagen serum transit bladder cancer patient urotheli basement membran ubm contain type iv collagen laminin fibronectin urotheli neoplasm break ubm under urothelium invad lamina propria conceptu bladder cancer stage ta may demonstr disturb... | D001749;D015374 | T191;T059;T075 |
36,272,275 | proteoexcel tp develop simpl excel base tool surrog peptid select mass spectrometri base target proteom select surrog peptid play major role achiev reproduc accur quantif desir protein target proteom current avail peptid select tool suffer limit cover entir protein includ speci inflex appli exclus criteria develop exce... | D040901;D010455 | T121;T116;T091 |
36,272,252 | sonochem synthesi biolog evalu isoquinolin h oneisoindolin one deriv discoveri posit ago alloster modul paam ht c r effort devot discoveri develop posit alloster modul pam ht c r potenti advantag orthoster agonist like lorcaserin withdrawn market hand pursu posit ago alloster modul paam consid benefici particular agoni... | D058826;D012701 | T121;T123;T109 |
36,272,251 | guaian type sesquiterpenoid various ring skeleton daphn bholua uncov molecular network structur revis previous report analogu genus daphn treasur hous secondari metabolit various biolog effect inspir daphn bholua fulli investig phytochem biolog first time seven undescrib guaian type sesquiterpenoid along thirteen known... | D032364;D012717 | T002;T109 |
36,272,240 | virtual realiti base theori mind intervent schizophrenia preliminari efficaci result recent year grow bodi literatur support core natur function signific theori mind tom deficit schizophrenia find made tom impair promis treatment target howev despit encourag result complex make difficult develop new intervent even unde... | D012559;D056345;D000076142 | T078;T066;T048 |
36,272,220 | mitochondria target supramolecular nanoplatform peroxynitrit potenti oxid therapi orthotop hepatoma oxid therapi generat reactiv oxygen speci ros via intracellular enzymat reaction achiev tumor ablat consid emerg approach cancer treatment herein nitric oxid combin oxid therapi report integr glutathion gsh sensit donor ... | D006528;D008113 | T191 |
36,272,219 | enhanc manipul tumor microenviron nanomotor synergist therapi malign tumor tumor microenviron tme play critic role growth metastasi tumor tissu provid promis way treat malign tumor via manipul tme howev develop proper strategi effect control tme still challeng herein ce peg msn pt capmp nanomotor fabric spontan move tu... | D010778;D053758 | T061;T073 |
36,272,218 | biocomposit cultur enhanc differenti dopamin like neuron sh syy cell model studi parkinson diseas phenotyp studi under neurodegen process parkinson diseas pd tradit util cell cultur grown two dimension surfac biomimet three dimension cell cultur platform develop better emul featur brain natur microenviron use bioengin ... | D010300;D009447 | T047;T191 |
36,272,208 | perceptu similar modul effect learn variabl face recognit face recognit challeng classif task human perform effortless familiar face recent studi emphas import exposur high variabl appear ident perform task howev studi explicit measur perceptu similar learn imag imag present test may account advantag learn high variabl... | D000066499 | T041 |
36,272,203 | general visuomotor adapt associ use depend learn across differ movement workspac limb postur use depend learn investig extent although motor pattern obtain use depend learn general across differ movement condit remain understood investig generaliz use depend learn determin visuomotor adapt associ use depend learn gener... | D011597;D009069 | T047;T041 |
36,272,202 | individu differ work memori capac conscious process explain explicit implicit learn outcom physic educ studi examin effect explicit versus implicit learn method motor learn self efficaci year old student n practic basketbal layup physic educ main aim test effect student verbal work memori capac wmc propens conscious mo... | D008570;D007206 | T054;T041 |
36,272,201 | preclin evalu new c label benzo dioxan pet radiotrac brain c adrenerg receptor one nine subtyp adrenerg receptor ar brain c ar play essenti role emot memori implic neuropsychiatr disord includ depress alzheim diseas substanc use disord schizophrenia recent develop c ar specif positron emiss tomographi pet radiotrac c o... | D018341;D010879 | T109;T116;T192 |
36,272,200 | energi expenditur glucos lower effect differ exercis modal diabet mellitus hypoglycaemia serious complic exercis patient type diabet mellitus tdm aim studi test energi expenditur degre glucos lower effect differ exercis modal | D003924;D007003 | T047 |
36,272,199 | comammox biogeographi subject anthropogen interfer along high altitud river recent discoveri comammox nitrospira perform complet ammonia oxid nitrat overturn long held dogma two step nitrif earth yet littl known effect urban interfer distribut use gene centric metagenom provid first blueprint comammox communiti biogeog... | D000641;D001105 | T194;T121;T197 |
36,272,198 | stage process challeng drawback lab full scale studi review respons grow global resourc scarciti wastewat increas seen valuabl resourc recov valoris benefit societi rather anoth wast need treatment dispos convent wastewat treatment plant wwtps oxidis organ matter present wastewat instead recov feedstock biomateri produ... | D012722;D062065 | T083;T069 |
36,272,197 | comprehens insight impact pretreat anaerob digest wast activ sludg perspect organ matter composit thermodynam multi omic although various pretreat appli promot anaerob digest wast activ sludg mechan regard impact pretreat anaerob digest well address studi effect acid alkali thermal pretreat anaerob digest comprehens in... | D012722;D014865 | T069;T057 |
36,272,196 | element sulfur base autotroph denitrif construct wetland effici approach nitrogen remov low cn wastewat construct wetland cws integr sulfur autotroph denitrif stimul high rate nitrogen remov carbon limit wastewat hold particular applic prospect due excess carbon sourc addit high effici good stabil studi conduct element... | D062065;D053833 | T083;T070;T069 |
36,272,174 | gut microbiota dysbiosi exagger ammonia induc tracheal injuri via tlr signal pathway ammonia toxic air pollut caus sever respiratori tract injuri anim human gut microbiota dysbiosi found involv develop respiratori tract injuri induc air pollut howev specif mechan requir investig found inhal ammonia induc tracheal injur... | D064806;D000069196 | T047;T046;T001;T007 |
36,272,173 | research molluscicid activ molecular mechan arecolin pomacea canaliculata pomacea canaliculata invas snail china advers affect agricultur crop yield ecolog environ human health paper studi molluscicid activ mechan arecolin p canaliculata molluscicid activ test show arecolin exhibit strong toxic p canaliculata lc valu h... | D008975;D049851 | T131;T204 |
36,272,156 | stabl core shell structur nanocryst cs pbbr zn moi achiev situ surfac reconstruct strategi optic anticounterfeit zero dimension cs pbbr nanocryst ncs possess attract photoluminesc pl properti featur facil chemic synthesi make promis applic luminesc materi howev cs pbbr remain sensit polar solvent thermal stimuli soft i... | D053758 | T073 |
36,272,107 | function coval organ framework peptid polym assist surfac modif applic protein detect although coval organ framework cof receiv extens attent biomed research due uniqu properti applic still hinder challeng incorpor cof function biomolecul sinc peptid shown advantag biomed applic herein propos function cof peptid polym ... | D000073396 | T109 |
36,272,098 | viral shed year follow first episod genit hsv infect herp simplex virus type hsv lead caus first episod genit herp mani countri | D006558;D018259;D015658;D006561 | T047;T005 |
36,272,033 | slca facilit epitheli cell ferroptosi via cebp pak axi ulcer coliti emerg evid suggest ferroptosi involv pathogenesi ulcer coliti uc howev key regul process remain uncertain studi aim explor role solut carrier slc famili member slca regul ferroptosi uc express slca signific increas posit associ prostaglandin endoperoxi... | D003093;D000079403 | T047;T043 |
36,272,024 | lenacapavir first approv lenacapavir sunlenca long act capsid inhibitor human immunodefici virus type hiv develop gilead scienc inc avail oral tablet inject solut latter slow releas formul allow bi annual subcutan administr august lenacapavir receiv first approv eu use combin antiretrovir adult multi drug resist hiv in... | D015658;D019380;D015497 | T121;T047;T005 |
36,272,023 | use mobil applic increas therapeut adher adult systemat review failur compli therapeut treatment impli negat repercuss patient qualiti life social environ health system use inform communic technolog especi mobil applic favor increas global therapeut adher figur object studi character use mobil applic strategi increas t... | D063731 | T170 |
36,271,991 | assess phenotyp divers within goliath chicken popul benin goliath chicken new strain poultri origin depart zou commune agbangnizoun republ benin characterist chicken strain well studi purpos studi character phenotyp divers goliath chicken depart zou couffo total bird made femal male sampl use morpholog descriptor resul... | D002645 | T012 |
36,271,974 | use object measur examin effect suspect filler similar eyewit identif perform select filler includ polic lineup one must consid level similar suspect potenti filler order reduc misidentif innoc suspect stand therefor import filler share degre similar import increas suspect filler similar much render task difficult redu... | D021641;D011939 | T041 |
36,271,971 | proteom alter clonal isol establish human pancreat cancer cell line clonal isol integr step numer workflow genom edit cell engin compris isol singl progenitor cell defin cell line popul subsequ expans obtain monoclon cell popul process associ transient loss cell cell contact absenc multicellular microenviron previous s... | D020543;D010190 | T123;T191;T116 |
36,271,963 | challeng osteoporosi treatment initi geriatr patient admit hip fractur pathway osteoporosi often untreat especi older peopl studi found low prescrib rate osteoporosi treatment medic older peopl admit hip fractur pathway factor associ greater odd prescrib osteoporosi medic categor patient relat physician relat system re... | D050071;D010024;D006620;D058866 | T121;T047;T037 |
36,271,960 | symmetri break longitud bifurc free boundari problem model small plaqu three dimens atherosclerosi one lead caus death usa worldwid begin lesion intima arteri wall allow ldl penetr intima oxid immun system consid oxid ldl danger substanc task macrophag attack incapacit macrophag becom foam cell lead format plaqu plaqu ... | D058226;D050197 | T047;T046;T020;T031 |
36,271,959 | milk product perform ankol crossbr holstein friesian cattl differ product environ rwanda aim studi assess product perform dairi cattl three differ agro ecolog zone rwanda congo nilewestern waz central plateaucentr caz eastern plateaueast agro ecolog zone eaz singl visit multi subject survey conduct obtain inform dairi ... | D008892;D003612 | T168;T092;T057;T031 |
36,271,951 | ost promiscu evolutionari biochem evalu hsd function cardiolipin metabol multifunct protein challeng difficult confirm pathomechan associ diseas caus genet variant human hydroxysteroid dehydrogenas hsd moonlight enzym least two structur catalyt unrel function hsd diseas origin describ disord isoleucin metabol clinic ma... | D015094;D006913 | T126;T116 |
36,271,948 | saliva metabolom profil covid patient associ diseas sever coronavirus diseas covid strong link dysregul various molecular cellular physiolog process chang abund differ biomolecul includ metabolit may ultim use biomark diseas progress sever import earli stage readili distinguish patient like progress moder sever stage | D000086382 | T047;T067 |
36,271,947 | start dose select palbociclib chines patient breast cancer base popul kinet pharmacodynam model neutropenia neutropenia common advers event ae palbociclib oral cdk inhibitor breast cancer neutropenia increas risk infect even life threaten asian patient general suffer sever neutropenia palbociclib treatment label recomm... | D001943;D009503 | T047;T191 |
36,271,946 | second extracellular proteas mediat matur vibrio mimicus hemolysin vibrio mimicus bacterium caus gastroenter human pathogen produc enterotox hemolysin call v mimicus hemolysin vmh secret extracellular inact kda protoxin convert kda matur toxin cleavag arg ser kda serin proteas term v mimicus trypsin like proteas vmta k... | D006460;D014733 | T123;T007 |
36,271,935 | immunogen third dose bntb covid vaccin patient cll effect treatment select patient chronic lymphocyt leukemia cll show suboptim respons vaccin sar cov shown though booster dose bntb vaccin may lead signific increas seroconvers rate immunocompromis patient conduct prospect non intervent studi evalu immunogen third dose ... | D015451;D000086382 | T047;T191;T067 |
36,271,888 | ev add databas ev associ dna human liquid biopsi sampl extracellular vesicl ev play key role cellular communic physiolog condit patholog cancer emerg evid shown ev activ carrier molecular cargo eg protein nucleic acid power sourc biomark target recent studi ev associ dna ev dna human biofluid generat larg amount data c... | D000067128;D009696 | T026;T123;T114 |
36,271,885 | provir role human respiratori epitheli cell deriv small extracellular vesicl sar cov infect small extracellular vesicl sev nm diamet vesicl delimit lipid bilay form within endosom network deriv plasma membran secret various biolog fluid includ airway nasal mucus goal work understand role sev present mucus mu sev produc... | D000086382;D000067128 | T026;T047;T067 |
36,271,851 | retrograd type aortic dissect differ evil retrograd type aortic dissect rtaad spontan secondari instrument descend thoraco abdomin aorta anatom differ compar antegrad type aortic dissect impact manag prognosi treatment standard report approach spontan rtaad institut n mean age year male aortic valv coronari arteri supr... | D019917;D000784;D017545 | T061;T047;T046 |
36,271,847 | laboratori signatur differenti toler hypotherm circulatori arrest acut type aortic dissect surgeri goal investig whether laboratori signatur admiss could use identifi risk stratif differ toler hypotherm circulatori arrest acut type aortic dissect surgeri | D000784;D006323;D017545 | T047;T046 |
36,271,846 | pegyl phosphatidylglyceroldocosahexaeno acid hexosom tocopheryl succin poli ethylen glycol induc morpholog transform vesicl prolong circul time consid broad therapeut potenti omega polyunsatur fatti acid docosahexaeno acid dha studi effect pegyl dha incorpor hexosom physicochem characterist biodistribut follow intraven... | D004281;D053758 | T123;T121;T073;T109 |
36,271,841 | target dna repair enhanc efficaci sorafenib hepatocellular carcinoma multityrosin kinas inhibitor sorafenib remain import system treatment option hepatocellular carcinoma hcc signal pathway target sorafenib involv checkpoint dna repair respons rad candid protein aim evalu effect human rad inhibitor b combin sorafenib h... | D006528;D008113;D000970 | T121;T191;T109 |
36,271,816 | studi hla class ii loci reveal dqb risk factor asthma pakistani popul asthma chronic inflammatori disord lung airway typic result combin multipl environment genet factor human leucocyt antigen hla region chromosom p encod high polymorph loci human genom encod gene central role immun function hla loci strong associ vari... | D001249 | T047 |
36,271,797 | molecular basi lethal cross talk two unrel bacteri transcript factor regulatori protein restrict modif system repressor defect prophag bacteri gene express depend effici function global transcript network howev interconnect orchestr reli main action individu dna bind protein call transcript factor tfs tfs interact spec... | D014157;D015280 | T123;T126;T116 |
36,271,789 | molecular basi cyclic tetra oligoadenyl process small standalon crispr cas ring nucleas standalon ring nucleas crispr ancillari protein downregul immun respons type iii crispr cas system cleav cyclic oligoadenyl ca second messeng two gene function found within sulfolobus islandicus sis genom code long polypeptid compos... | D064130 | T123;T116 |
36,271,755 | network effect brain lesion caus central poststrok pain studi undertaken test whether lesion caus central poststrok pain cpsp associ specif connect profil whether connect associ metabol chang whether network align neuromodul target pain | D063132;D009437;D009422 | T184;T047;T017;T091 |
36,271,736 | mechan chlorat toxic resist pseudomona aeruginosa pseudomona aeruginosa opportunist bacteri pathogen often encount hypoxicanox environ within host increas toler mani convent antibiot toward identifi novel treatment explor therapeut potenti chlorat pro drug kill hypoxicanox antibiot toler p aeruginosa popul chlorat rela... | D002704;D011355 | T120;T121;T197 |
36,271,735 | methionin oxid anaerob condit escherichia coli repair oxid target macromolecul central mechan necessari live organ adapt oxid stress reactiv oxygen chlorin speci preferenti oxid sulfur contain amino acid protein among amino acid methionin convert methionin sulfoxid post translat oxid revers methionin sulfoxid reductas ... | D004926;D033903 | T123;T007;T116 |
36,271,686 | get clock back feet target circadian clock treat osteoarthr grow evid suggest circadian clock dysfunct may contribut patholog osteoarthr issu et al use vivo human deriv osteoarthr model demonstr therapeut potenti pharmacolog manipul compon cartilag circadian clock author provid import proof principl support circadian c... | D057906;D010003 | T047;T040 |
36,271,674 | chitotriosidas biomark adult onset leukoencephalopathi axon spheroid pigment glia adult onset leukoencephalopathi axon spheroid pigment glia alsp lead rapid progress dementia caus mutat gene csfr neurodegener driven dysfunct microglia predomin cell type express csfr brain assess chitotriosidas enzym secret microglia se... | D056784 | T047 |
36,271,631 | effect chromium vi toxic benzo z pyren hbe cell contamin human habitat complex mixtur heavi metal polycycl aromat hydrocarbon pah import environment industri health problem hexaval chromium cr vi benzo pyren b p typic two respect recent decad great deal research focus carcinogen mechan action howev studi conduct evalu ... | D001564;D002857 | T121;T196;T131;T109 |
36,271,607 | congenit esophag stenosi caus tracheobronchi remnant case report describ case congenit esophag stenosi patient underw ineffect balloon dilat twice eventu requir surgeri case initi misdiagnos achalasia patholog find reveal tracheobronchi remnant tbrs muscular layer strictur esophag tissu tbr strictur locat middl lower t... | D004940;D013505;D005764 | T061;T047 |
36,271,606 | associ parafibromin express presenc brown tumor jaw tumor patient primari hyperparathyroid seri case review literatur background brown jaw tumor rare entiti poor understood etiolog regard end stage bone remodel patient long last chronic hyperparathyroid jaw tumor main diagnos jaw tumor syndrom hpt jt syndrom caus mutat... | D049950;D007573;D010282;D005350 | T047;T191 |
36,271,599 | fast blood glucos predictor progress infarct men acut ischem stroke blood glucos relat earli neurolog deterior acut ischem stroke multipl mechan involv earli neurolog deterior progress infarct studi aim determin whether fast blood glucos fbg independ predictor progress infarct | D000083242;D006943;D020521 | T033;T047 |
36,271,588 | advanc previous two decad understand post translat modif function drug perspect argbp famili member arginin kinas bind protein argbp adapt protein belong sorbin homolog soho famili soho famili also includ c cbl associ protein cap vinexin share structur function similar argbp howev role soho famili protein cell signal d... | D001122 | T126;T116 |
36,271,587 | histon deacetylas inhibitor enhanc oncolyt herp simplex virus therapi malign meningioma approxim meningioma benign higher grade tend relaps surgeri radiat therapi malign anaplast meningioma mm minor subset high grade meningioma lethal effect treatment option current oncolyt herp simplex virus ohsv power anti cancer mod... | D008579;D006561;D008577 | T047;T191 |
36,271,586 | lipid polym nanocarri platform enabl x ray induc photodynam therapi human colorect cancer cell studi brought togeth x ray induc photodynam therapi x pdt chemo drug fu treatment colorect cancer cell achiev develop lipid polym hybrid nanoparticl deliveri system fa lpnps vp fu prepar incorpor photosensit verteporfin chemo... | D010778;D053758;D000970;D015179 | T061;T121;T073;T109;T191 |
36,271,585 | acid sens ion channel potenti therapeut target tumor acid extracellular ph major characterist tumor tissu studi suggest local ph valu malign tumor tissu acid sens ion channel asic proton gate cation channel activ low extracellular ph recent increas number studi suggest asic involv differ kind tumor play import role occ... | D062565;D009369 | T123;T191;T116 |
36,271,584 | si wu tang amelior bile duct ligat induc liver fibrosi via modul immun environ si wu tang swt tradit chines medicin formula first record tang dynasti report allevi gynecolog liver diseas preliminarili demonstr swt could improv liver fibrosi via modul intestin microbiota littl known mechan link therapeut effect reshap i... | D018414;D008103 | T047;T025 |
36,271,583 | skelet muscl mitochondri remodel heart failur updat mechan therapeut opportun patient heart failur hf usual present skelet muscl diseas vari sever rang earli fatigu exercis sarcopenia sarcopen obes cachexia frailti signific predictor hf prognosi abnorm mitochondri metabol identifi one earliest sign skelet muscl injuri ... | D006333;D055948;D001688 | T121;T123;T047;T046 |
36,271,582 | geniposid amelior glucocorticoid induc osteoblast apoptosi activ autophagi long term exposur glucocorticoid gc contribut develop osteoporosi op correl risk fractur patholog gc induc bone loss associ osteoblast apoptosi geniposid gen natur occur compound deriv eucommia ulmoid report amelior dexamethason dex induc op pre... | D005938;D010024 | T125;T047;T039;T109 |
36,271,581 | gut microbiota new insight lung diseas human gut microbiota complex ecosystem involv metabol immun health host microbiom play key role develop host innat adapt immun system immun system orchestr mainten host microb symbiosi lung diseas usual accompani dysbiosi intestin flora immun inflammatori respons intestin flora me... | D000069196;D000086382;D064307 | T007;T032;T067;T028;T047;T001 |
36,271,580 | comparison psychoact activ four primari areca nut alkaloid zebrafish behavior approach molecular dock areca palm nut areca catechu list one addict substanc along tobacco alcohol caffein belong famili arecacea wide use asia areca nut contain seven psychoact alkaloid howev effect alkaloid behavior rare address zebrafish ... | D001114;D000470 | T121;T123;T109;T131;T002 |
36,271,579 | effect sedi herba sedum sarmentosum attenu cholestasi activ farnesoid x receptor fxr mediat signal sedum sarmentosum sedi herba tradit use treat jaundic various type liver diseas studi aim clarifi anti cholestat efficaci mechan sarmentosum ethyl acet extract sdeae well screen potenti compound fxr activ sdeae effect ame... | D031963;D002779 | T047;T002 |
36,271,578 | transplant adipos deriv mesenchym stem cell amelior acut hepat injuri caus nonsteroid anti inflammatori drug diclofenac sodium femal rat although benefici role adipos deriv mesenchym stem cell ad mscs acut liver injuri address numer studi employ differ liver injuri induc role rat ad mscs rad mscs diclofenac sodium dic ... | D045164;D059630 | T061;T025 |
36,271,577 | hypertens vascular cardiac remodel protect allicin spontan hypertens rat via camk nf b pathway allicin main activ compon tradit chines medicin garlic wide use treat cardiovascular diseas previous studi confirm allicin signific reduc blood pressur spontan hypertens rat shrs howev report studi effect allicin vascular car... | D016328;D006973 | T129;T047;T116 |
36,271,576 | hoxa crucial transcript factor cancer potenti therapeut target hox gene occupi signific role embryogenesi hematopoiesi oncogenesi hoxa member cluster hox gene essenti establish skeleton normal organogenesi previous report aberr hoxa express contribut anomali dysfunct various organ well affect prolifer differenti invas ... | D005801;D009369 | T191;T028 |
36,271,575 | protect effect thymoquinon orand thymol monosodium glutam induc attent deficithyperact disord adhd like behavior rat modul nrfho tlrnf bnlrpcaspas wnt catenin signal pathway rat model thymoquinon tq thymol prove possess posit impact human health research aim investig effect compound separ togeth attent deficithyperact ... | D001289;D012970 | T121;T168;T116;T048 |
36,271,574 | therapeut efficaci scutellaria baicalensi georgi psoriasi like lesion via regul respons keratinocyt macrophag psoriasi chronic recurr skin problem affect global popul nowaday medicin may promis complet cure patient psoriasi develop pharmacoresist side effect drug due microenviron impact context skin imbal herein attemp... | D031364;D011565 | T047;T002 |
36,271,573 | natur product target atr chk signal pathway cancer therapi cancer one sever medic condit world caus million death year chemotherapi radiotherapi critic treatment approach numer advers health effect furthermor resist cancer cell anticanc medic lead treatment failur rise burden cancer requir novel efficaci treatment moda... | D001688;D009369 | T123;T121;T191 |
36,271,572 | effect psidium guajava l leav extract blood pressur control il product salt depend hypertens rat psidium guajava guava leav extract display anti hypertens properti mechan yet fulli understood investig whether sympathet drive immun signal mechan involv antihypertens effect guava extract model salt depend hypertens raw g... | D031647;D006973 | T168;T047;T002 |
36,271,571 | rafoxanid sensit colorect cancer cell trail mediat apoptosi colorect cancer crc remain lead caus cancer relat death world main due lack effect treatment advanc diseas tnf relat apoptosi induc ligand trail driven cell death crucial event control tumor growth select target malign rather non transform cell howev fact canc... | D000970;D015179 | T121;T191;T109 |
36,271,570 | bromo dihydroxybenzaldehyd attenu endotheli cell injuri high glucos induc damag hyperglycemia trigger metabol inflammatori respons lead vascular inflamm consequ induc microvascular andor macrovascular diabet complic bromo dihydroxybenzaldehyd bdb marin red alga deriv bromophenol compound found divers bioactiv includ ef... | D016328;D006943 | T033;T129;T047;T116 |
36,271,569 | target pharmacokinet bioinformat screen strategi reveal jak main target xin ji er kang treatment mir injuri xin ji er kang xjek tradit chines formula present excel protect effect sever heart diseas potenti compon target still unclear aim studi elucid effect compon xjek reveal potenti mechan cardioprotect effect myocard... | D015428;D000470 | T121;T123;T109;T131;T046 |
36,271,568 | metal metal oxid deriv nanohybrid tool biomed applic nanotechnolog cover varieti scientif area includ chemistri materi scienc physic biomedicin biolog engin metal nanohybrid extraordinari properti high research comparison bulki individu nanoparticl especi metal metal oxid nanoparticl new class function nanohybrid broad... | D010087;D053768 | T197;T073 |
36,271,567 | combin niclosamid current therapi overcom resist cancer new frontier old drug niclosamid drug use treat parasit infect recent studi shown niclosamid may wide rang clinic applic use treat cancer diseas howev applic also limit water solubl safeti drug resist cancer solv problem studi shown niclosamid use combin chemother... | D009369;D000970 | T121;T191;T109 |
36,271,566 | chemic fingerprint compar vitro antioxid properti biochem effect ginger bitterleaf infus botan remark pharmacolog properti includ zingib officinal rosco zingiberacea ginger gymnanthemum amygdalinum deli sch bip asteracea bitterleaf plant frequent use tea decoct studi treatment various ill thus studi investig vitro anti... | D020939 | T002 |
36,271,565 | pattern immun infiltr surviv endocrin therapi treat er posit breast cancer comput studi patient tumor infiltr immun cell tiic play critic role breast cancer bc prognosi littl known regard efficaci endocrin therapi patient er posit bc divers immunolog phenotyp investig whether tiic affect surviv endocrin therapi patient... | D016246;D009364 | T191;T025 |
36,271,564 | recent advanc respiratori diseas dietari carotenoid choic therapeut group bioactiv isoprenoid pigment known carotenoid most present fruit veget carotenoid essenti prevent physiolog issu make maintain excel health easier effect function ingredi potent health promot properti wide present food link decreas preval chronic ... | D002338;D000975 | T123;T121;T109;T039;T044 |
36,271,563 | purin metabol develop osteoporosi osteoporosi common bone metabol diseas postmenopaus women diabet patient obes patient character imbal bone format resorpt current studi conduct depth research group reveal respect pathogenesi treatment measur howev caus osteoporosi patient complex usual combin multipl factor unifi path... | D001862;D010024 | T047;T042 |
36,271,562 | genet delet hpv e oncogen effect regress hpv driven oral squamous carcinoma tumour growth major hpv oncogen e e known notorieti drive carcinogen process human papilloma virus hpv driven cancer well establish remov e dampen hpv cancer cell growth prolifer made e attract target hpv cancer semin work laboratori employ cri... | D052685;D002583;D009856;D030361;D002294;D009062 | T123;T116;T191;T005;T047 |
36,271,561 | scutellarin amelior osteoarthr protect chondrocyt subchondr bone microstructur inactiv nf bmapk signal transduct osteoarthr oa chronic degen diseas major caus pain disabl reduc qualiti life among elder worldwid key treat earli prevent effect intervent anti inflammatori effect scutellarin scu flavonoid deriv erigeron br... | D019902;D010003 | T047;T025 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.